Developing new methods to target the influenza A virus
Targeting Influenza A Virus by a Carbohydrate-inspired Strategy
This study is working on better ways to prevent and treat the flu, especially the 1918 H1N1 strain, by creating new antiviral medicines and faster tests to identify different flu types, which could help us understand how the virus affects our lungs and improve how we diagnose and treat it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11026400 on NIH RePORTER |
What this research studies
This research focuses on improving the prevention and treatment of influenza A virus, particularly the 1918 H1N1 strain, by developing new antiviral drugs and diagnostic tools. It aims to create a rapid and precise method for detecting specific influenza variants using advanced glycan arrays. The study will explore the interaction between the virus and the respiratory tract's sialoside receptors to enhance our understanding of infection mechanisms. By synthesizing complex glycans that mimic those found in the respiratory tract, the research seeks to improve current diagnostic capabilities and therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for influenza A virus infections, such as those with compromised immune systems or chronic respiratory conditions.
Not a fit: Patients who are not affected by influenza A virus or those who have already been vaccinated against it may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective antiviral treatments and better diagnostic methods for influenza A virus infections.
How similar studies have performed: Previous research has shown promise in developing antiviral strategies targeting influenza viruses, indicating that this approach could yield significant advancements.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Wong, Chi-Huey — Scripps Research Institute, the
- Study coordinator: Wong, Chi-Huey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.